LLY Q3 2019 Earnings Report — Eli Lilly and Company Revenue & Financial Results | Market Cap Arena

Eli Lilly and CompanyLLY

Q3 2019 Earnings

Reported October 25, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q3 2019	Q2 2019	Q3 2018	QoQ Change	YoY Change
Revenue	$5.5B	$5.6B	$5.3B	-2.8%	3.2%
Op. Income	$1.6B	$1.6B	$1.5B	-0.8%	5.6%
Gross Margin	78.5%	80.0%	78.3%	-1.5pp	0.3pp
Net Margin	22.9%	23.5%	21.7%	-0.7pp	1.2pp
EPS (Diluted)	$1.31	$1.37	$1.12	-4.4%	17.0%
Free Cash Flow	$1.2B	$766M	$1.8B	52.6%	-35.8%

Revenue Flow

Item	Amount
REVENUE	$5.5B
Cost of Revenue	$1.2B
GROSS PROFIT	$4.3B
R&D Expenses	$1.4B
Selling & Marketing	$0
General & Administrative	$1.4B
SG&A Expenses	$1.4B
Other Expenses	$0
Operating Expenses	$2.7B
Cost & Expenses	$3.9B
OPERATING INCOME	$1.6B
Interest Income	$17M
Interest Expense	$107M
Other Income/Expenses	-$155M
INCOME BEFORE TAX	$1.4B
Income Tax Expense	$152M
Net Income from Continuing Ops	$1.3B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.3B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.3B
D&A	$288M
EBIT	$1.5B
EBITDA	$1.8B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$5.5B
Cost of Revenue	$1.2B
GROSS PROFIT	$4.3B
R&D Expenses	$1.4B
Selling & Marketing	$0
General & Administrative	$1.4B
SG&A Expenses	$1.4B
Other Expenses	$0
Operating Expenses	$2.7B
Cost & Expenses	$3.9B
OPERATING INCOME	$1.6B
Interest Income	$17M
Interest Expense	$107M
Other Income/Expenses	-$155M
INCOME BEFORE TAX	$1.4B
Income Tax Expense	$152M
Net Income from Continuing Ops	$1.3B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$1.3B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$1.3B
D&A	$288M
EBIT	$1.5B
EBITDA	$1.8B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$1.3B
Depreciation & Amortization	$288M
Stock-Based Compensation	$76M
Deferred Income Tax	-$12M
Other Non-Cash Items	$152M
Change in Working Capital	-$247M
OPERATING CASH FLOW	$1.5B
Capital Expenditure	-$341M
Acquisitions (Net)	$0
Purchases of Investments	-$50M
Sales/Maturities of Investments	$109M
Other Investing Activities	-$142M
NET CASH FROM INVESTING	-$424M
Net Debt Issuance	-$506M
Common Stock Repurchased	-$600M
Common Dividends Paid	-$587M
Other Financing Activities	$0
NET CASH FROM FINANCING	-$1.7B
FREE CASH FLOW	$1.2B
Net Change in Cash	-$726M

Balance Sheet

Item	Amount
Cash & Equivalents	$1.6B
Short-Term Investments	$89M
Net Receivables	$5.5B
Inventory	$3.1B
Other Current Assets	$0
TOTAL CURRENT ASSETS	$12.7B
PP&E (Net)	$8.3B
Goodwill	$3.8B
Intangible Assets	$6.7B
Long-Term Investments	$1.8B
Tax Assets	$2.4B
Other Non-Current Assets	$2.2B
TOTAL NON-CURRENT ASSETS	$25.2B
TOTAL ASSETS	$37.9B
Account Payables	$1.1B
Short-Term Debt	$1.6B
Deferred Revenue	$0
Other Current Liabilities	$7.3B
TOTAL CURRENT LIABILITIES	$10.8B
Long-Term Debt	$13.7B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2.4B
Other Non-Current Liabilities	$7.0B
TOTAL NON-CURRENT LIABILITIES	$23.6B
TOTAL LIABILITIES	$34.4B
Common Stock	$600M
Additional Paid-In Capital	$6.6B
Retained Earnings	$5.0B
Treasury Stock	-$61M
Accum. Other Comp. Income	-$5.7B
Other Equity	-$3.0B
TOTAL STOCKHOLDERS' EQUITY	$3.4B
Minority Interest	$80M
TOTAL EQUITY	$3.5B
TOTAL LIABILITIES & EQUITY	$37.9B
Total Debt	$15.7B
Net Debt	$14.1B